Kestra Medical (KMTS) Director Raymond Cohen Sells 3,330 Shares

What Happened
Raymond W. Cohen, a director of Kestra Medical Technologies, sold 3,330 shares on 2026-09-30 in an open‑market transaction at a weighted average price of $29.28, generating approximately $97,504 in proceeds. The Form 4 notes this was a nondiscretionary "sell-to-cover" sale to satisfy tax withholding obligations related to the vesting and settlement of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-09-30; Form 4 filed: 2026-10-01 (no late filing indicated).
• Price: weighted average $29.28; reported sale prices ranged $29.2800–$29.2900.
• Shares sold: 3,330; proceeds ≈ $97,504.
• Transaction type/code: Open-market sale (S); footnote specifies sell-to-cover for tax withholding (F1).
• Shares owned after the transaction: not disclosed in the provided filing.
• Footnote F2: the filing reports a weighted average price and offers to provide the per-price share breakdown on request.

Context
A sell-to-cover tied to RSU vesting is a routine administrative transaction to cover taxes and does not necessarily indicate the director's view of the company. Purchases by insiders are generally more informative about confidence; sales for tax withholding are common and often neutral.